Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: Secondary analysis of a randomised, placebo-controlled trial

The Lancet Infectious Diseases

Volumn 15, Issue 6, 2015, Pages 654-662

  Fry, Alicia M ^a   Goswami, Doli ^b   Nahar, Kamrun ^b   Sharmin, Amina T ^b   Rahman, Mustafizur ^b   Gubareva, Larisa ^a   Trujillo, Alma ^a   Barnes, John ^a   Azim, Tasnim ^b   Bresee, Joseph ^a   Luby, Stephen P ^c   Brooks, W Abdullah ^b,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c STANFORD UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PLACEBO; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; BANGLADESH; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG USE; FEMALE; HOUSEHOLD; HUMAN; INFLUENZA; INFLUENZA VIRUS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCIENTIST; SECONDARY ANALYSIS; URBAN AREA; AGED; FAMILY HEALTH; FAMILY SIZE; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; TRANSMISSION; TREATMENT OUTCOME; URBAN POPULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BANGLADESH; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FAMILY CHARACTERISTICS; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; PLACEBOS; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

EID: 84929505469     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)70041-1     Document Type: Article

References (17)

1. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452.
2. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999, 341:1336-1343.
3. Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of influenza in families; Zanamivir Family Study Group. N Engl J Med 2000, 343:1282-1289.
4. Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001, 285:748-754.
5. Monto AS, Robinson DP, Herlocher ML, Hinson JM, Elliott MJ, Crisp A Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999, 282:31-35.
6. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001, 20:127-133.
7. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000, 355:1845-1850.
8. Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 1997, 337:874-880.
9. Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007, 165:212-221.
10. Ng S, Cowling BJ, Fang VJ, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 2010, 50:707-714.
11. Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Lancet Infect Dis 2014, 14:109-118.
12. Brooks WA, Breiman RF, Goswami D, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 2007, 77:795-801.
13. Sequencing primers and protocols Centers for Disease Control, (accessed Nov 10, 2014). http://www.who.int/csr/resources/publications/swineflu/sequencing_primers/en/.
14. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009, 361:2619-2627.
15. Monto AS, Kioumehr F The Tecumseh study of respiratory illness IX. Occurence of influenza in the community, 1966-1971. Am J Epidemiol 1975, 102:553-563.
16. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000, 284:1677-1682.
17. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerg Infects Dis 2009, 15:365-371. DS Fedson.